VS-7375 produced a responses previously treated metastatic pancreatic ductal adenocarcinoma.
Related to this article
Japan approved Optune Pax plus gemcitabine and nab-paclitaxel for unresectable locally advanced pancreatic cancer.
Advertisement
Advertisement
Trending on OncLive
1
Lifileucel Linked to Low Rates of Post-Discharge Severe TRAEs, Readmissions in Advanced Melanoma
2
VS-7375 Elicits Responses in KRAS G12D–Mutated Pancreatic Cancer
3
Chronicity of Immune-Related AEs Drives QOL Burden With Adjuvant Checkpoint Inhibition in Resected RCC
4
Sequencing B7-H4–Targeted ADCs and Optimizing Toxicity Management in Gynecologic Cancers
5